Recombinant von Willebrand factor for von Willebrand disease: mechanism of action and clinical application
Von Willebrand disease (VWD) is an inherited bleeding disorder resulting from a deficiency in von Willebrand factor (VWF), either quantitative or qualitative. Recombinant VWF (rVWF) presents a novel therapeutic option for patients with VWD. Produced in Chinese hamster ovary cells, rVWF is free of an...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publishing
2026-02-01
|
| סדרה: | Therapeutic Advances in Hematology |
| גישה מקוונת: | https://doi.org/10.1177/20406207261419941 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|